These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21318767)

  • 1. α-Synuclein/Amyloid Interactions.
    Henning Jensen P
    Methods Mol Med; 2001; 62():61-5. PubMed ID: 21318767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metals accelerate the formation and direct the structure of amyloid fibrils of NAC.
    Khan A; Ashcroft AE; Higenell V; Korchazhkina OV; Exley C
    J Inorg Biochem; 2005 Sep; 99(9):1920-7. PubMed ID: 16087241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC.
    Jensen PH; Hojrup P; Hager H; Nielsen MS; Jacobsen L; Olesen OF; Gliemann J; Jakes R
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):539-46. PubMed ID: 9163350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
    El-Agnaf OM; Irvine GB
    J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein.
    Bisaglia M; Trolio A; Tessari I; Bubacco L; Mammi S; Bergantino E
    Protein Expr Purif; 2005 Jan; 39(1):90-6. PubMed ID: 15596364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease.
    Yumoto S; Kakimi S; Ohsaki A; Ishikawa A
    J Inorg Biochem; 2009 Nov; 103(11):1579-84. PubMed ID: 19744735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
    Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
    Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Defect Conferred by the Parkinson's Disease-Causing α-Synuclein (Ala30Pro) Mutation.
    Henning Jensen P
    Methods Mol Med; 2001; 62():67-72. PubMed ID: 21318768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.
    Xia Y; Rohan de Silva HA; Rosi BL; Yamaoka LH; Rimmler JB; Pericak-Vance MA; Roses AD; Chen X; Masliah E; DeTeresa R; Iwai A; Sundsmo M; Thomas RG; Hofstetter CR; Gregory E; Hansen LA; Katzman R; Thal LJ; Saitoh T
    Ann Neurol; 1996 Aug; 40(2):207-15. PubMed ID: 8773602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
    Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
    J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.